These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 27301202)
1. Genotyping of Pseudomonas aeruginosa Type III Secretion System Using Magnetic Enrichment Multiplex Polymerase Chain Reaction and Chemiluminescence. Tang Y; Li B; Dai J; Dai J; Wang X; Si J; Ali Z; Li T; He N J Biomed Nanotechnol; 2016 Apr; 12(4):762-9. PubMed ID: 27301202 [TBL] [Abstract][Full Text] [Related]
2. Development of loop-mediated isothermal amplification assays for genotyping of Type III Secretion System in Pseudomonas aeruginosa. Shi H; Chen Z; Kan J Lett Appl Microbiol; 2015 Oct; 61(4):361-6. PubMed ID: 26219625 [TBL] [Abstract][Full Text] [Related]
3. Type 3 secretion system effector genotype and secretion phenotype of longitudinally collected Pseudomonas aeruginosa isolates from young children diagnosed with cystic fibrosis following newborn screening. Hu H; Harmer C; Anuj S; Wainwright CE; Manos J; Cheney J; Harbour C; Zablotska I; Turnbull L; Whitchurch CB; Grimwood K; Rose B; Clin Microbiol Infect; 2013 Mar; 19(3):266-72. PubMed ID: 22329595 [TBL] [Abstract][Full Text] [Related]
4. Characterization of Virulence Genes Associated with Type III Secretion System and Biofilm Formation in Pseudomonas aeruginosa Clinical Isolates. Ali ASBE; Ozler B; Baddal B Curr Microbiol; 2023 Oct; 80(12):389. PubMed ID: 37880467 [TBL] [Abstract][Full Text] [Related]
5. Prevalence of type III secretion genes in clinical and environmental isolates of Pseudomonas aeruginosa. Feltman H; Schulert G; Khan S; Jain M; Peterson L; Hauser AR Microbiology (Reading); 2001 Oct; 147(Pt 10):2659-2669. PubMed ID: 11577145 [TBL] [Abstract][Full Text] [Related]
6. Difference of Type 3 secretion system (T3SS) effector gene genotypes (exoU and exoS) and its implication to antibiotics resistances in isolates of Pseudomonas aeruginosa from chronic otitis media. Park MH; Kim SY; Roh EY; Lee HS Auris Nasus Larynx; 2017 Jun; 44(3):258-265. PubMed ID: 27461174 [TBL] [Abstract][Full Text] [Related]
7. Molecular detection of type III secretory toxins in Pseudomonas aeruginosa isolates. Jarjees KK Cell Mol Biol (Noisy-le-grand); 2020 Jul; 66(5):9-14. PubMed ID: 33040805 [TBL] [Abstract][Full Text] [Related]
8. Single-nucleotide-polymorphism mapping of the Pseudomonas aeruginosa type III secretion toxins for development of a diagnostic multiplex PCR system. Ajayi T; Allmond LR; Sawa T; Wiener-Kronish JP J Clin Microbiol; 2003 Aug; 41(8):3526-31. PubMed ID: 12904350 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of biofilm production and characterization of genes encoding type III secretion system among Pseudomonas aeruginosa isolated from burn patients. Jabalameli F; Mirsalehian A; Khoramian B; Aligholi M; Khoramrooz SS; Asadollahi P; Taherikalani M; Emaneini M Burns; 2012 Dec; 38(8):1192-7. PubMed ID: 22995427 [TBL] [Abstract][Full Text] [Related]
10. Prevalence of Type III Secretion System (T3SS) and Biofilm Development in Genetically Heterogeneous Clinical Isolates of Pseudomonas aeruginosa from Nigeria. Olaniran OB; Donia A; Adeleke OE; Bokhari H Curr Microbiol; 2023 Sep; 80(11):349. PubMed ID: 37733140 [TBL] [Abstract][Full Text] [Related]
11. Diverse type III secretion phenotypes among Pseudomonas aeruginosa strains upon infection of murine macrophage-like and endothelial cell lines. Stepińska M; Trafny EA Microb Pathog; 2008 May; 44(5):448-58. PubMed ID: 18221854 [TBL] [Abstract][Full Text] [Related]
12. Study on Virulence Genes of Type III Secretion System of Pseudomonas aeruginosa in Xinjiang Province. Yi H; Sun Q; Wang X; Liu Y; Feng N; Zhang L; Song W; Shang X; Li X; Ma X Clin Lab; 2021 Aug; 67(8):. PubMed ID: 34383413 [TBL] [Abstract][Full Text] [Related]
13. High incidence of type III secretion system associated virulence factors (exoenzymes) in Pseudomonas aeruginosa isolated from Iranian burn patients. Khodayary R; Nikokar I; Mobayen MR; Afrasiabi F; Araghian A; Elmi A; Moradzadeh M BMC Res Notes; 2019 Jan; 12(1):28. PubMed ID: 30646938 [TBL] [Abstract][Full Text] [Related]
14. Sarges EDSNF; Rodrigues YC; Furlaneto IP; de Melo MVH; Brabo GLDC; Lopes KCM; Quaresma AJPG; Lima LNGC; Lima KVB Infect Drug Resist; 2020; 13():3771-3781. PubMed ID: 33116695 [TBL] [Abstract][Full Text] [Related]
15. Epithelial cell lysates induce ExoS expression and secretion by Pseudomonas aeruginosa. Hritonenko V; Metruccio M; Evans D; Fleiszig S FEMS Microbiol Lett; 2018 Apr; 365(8):. PubMed ID: 29518189 [TBL] [Abstract][Full Text] [Related]
16. Novel type III effectors in Pseudomonas aeruginosa. Burstein D; Satanower S; Simovitch M; Belnik Y; Zehavi M; Yerushalmi G; Ben-Aroya S; Pupko T; Banin E mBio; 2015 Mar; 6(2):e00161. PubMed ID: 25784698 [TBL] [Abstract][Full Text] [Related]
17. Presence of exoY, exoS, exoU and exoT genes, antibiotic resistance and biofilm production among Pseudomonas aeruginosa isolates in Northwest Iran. Azimi S; Kafil HS; Baghi HB; Shokrian S; Najaf K; Asgharzadeh M; Yousefi M; Shahrivar F; Aghazadeh M GMS Hyg Infect Control; 2016; 11():Doc04. PubMed ID: 26958458 [TBL] [Abstract][Full Text] [Related]
18. [Carriage of the Pseudomonas aeruginosa virulence factors and prognosis after infection]. Zhao RZ; Zheng YJ; Chen Q Zhonghua Er Ke Za Zhi; 2012 Sep; 50(9):672-7. PubMed ID: 23158816 [TBL] [Abstract][Full Text] [Related]
19. ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury. Finck-Barbançon V; Goranson J; Zhu L; Sawa T; Wiener-Kronish JP; Fleiszig SM; Wu C; Mende-Mueller L; Frank DW Mol Microbiol; 1997 Aug; 25(3):547-57. PubMed ID: 9302017 [TBL] [Abstract][Full Text] [Related]
20. Association between Pseudomonas aeruginosa type III secretion, antibiotic resistance, and clinical outcome: a review. Sawa T; Shimizu M; Moriyama K; Wiener-Kronish JP Crit Care; 2014 Dec; 18(6):668. PubMed ID: 25672496 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]